nausea%20-and-%20vomiting%20in%20pregnancy
NAUSEA & VOMITING IN PREGNANCY
Nausea & vomiting in pregnancy (NVP), commonly known as "morning sickness", affects 50-90% of pregnant women.
In most women, the condition manifests between the 4th-7th week after last menstrual period and resolves by the 16th week of gestation.
It manifests in a spectrum of severity from mild nausea to very rare life-threatening symptoms.
The etiology is multifactorial.
The pregnant woman's sense of well-being and her daily activities are greatly affected by nausea and vomiting; the physical and emotional impact often leads to anxiety and worry about the effect of the symptoms on the fetus and reduced job efficiency.
  1. Black A, Francouer D, Rowe T, et al. SOGC clinical practice guidelines: Canadian contraception consensus. J Obstet Gynaecol Can. 2004 Mar;26(3):219-296. PMID: 15016334
  2. American College of Obstetricians and Gynecologists (ACOG). American College of Obstetrics and Gynecology Practice Bulletin: nausea and vomiting of pregnancy. Obstet Gynecol. 2004 Apr;103(4):803-814. PMID: 15051578
  3. American Society for Parenteral and Enteral Nutrition-Professional Association. Specific guidelines for disease-adults. J Parenter Enteral Nutr. 2006;26(1 Suppl):61SA-96SA
  4. Eliakim R, Abuafia O, Sherer DM. Hyperemesis gravidarum: a current review. Am J Perinatol. 2000;17(4):207-218. PMID: 11041443
  5. Harker N, Montogomery A, Fahey T. Treating nausea and vomiting during pregnancy: case outcome. BMJ. 2004 Feb;328(7438):503-504. PMID: 14988187
  6. Arsenault M, Lane C. The management of nausea and vomiting of pregnancy. J Obstet Gynaecol Can. 2002 Oct;24(10):817-823. PMID: 12405123
  7. Quinlan J, Hill D. Nausea and vomiting in pregnancy. Am Fam Physician. 2003 Jul;68(1):121-128. PMID: 12887118
  8. Dulay AT. Hyperemesis Gravidarum. Merck Manual; 2010 Feb. http://www.merckmanuals.com. Accessed 27 May 2013.
  9. MedWormhttp://www.medworm.com/rss/index.php/Gastroenterology/17/http://www.medworm.com/rss/medicalfeeds/specialities/Gastroenterology.xml
  10. MedWormhttp://www.medworm.com/rss/index.php/OBGYN/29/http://www.medworm.com/rss/medicalfeeds/specialities/OBGYN.xml
  11. American College of Obstetrics and Gynecologists (ACOG). ACOG issues guidance on treatment of morning sickness during pregnancy. http://www.acog.org. Mar 2004.
  12. Practical Support for Clinical Governance. PRODIGY Guidance-Nausea and vomiting in pregnancy. http://www.prodigy.nhs.uk.
  13. Edelman A. Pregnancy, hyperemesis gravidarum. eMedicine. http://www.emedicine.com. May 2004.
  14. Smith JA, Refuerzo JS, Ramin SM. Treatment and outcome of nausea and vomiting of pregnancy. UpToDate. http://www.uptodate.com. 30 Apr 2014.
  15. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. J Parenter Enteral Nutr. 2002;26(1 Suppl):61SA-96SA. PMID: 11841046
  16. Endjun JJ, Rumondang A, Julianti RA. Mual Muntah dalam kehamilan. Divisi Kedokteran Fetomaternal, Departemen Obstetri dan Ginekologi, FKUI - RSPAD Gatot Soebroto. Jakarta; 2015.
  17. Shehmar M, Maclean MA, Nelson-Piercy C, et al. The management of nausea and vomiting of pregnancy and hyperemesis gravidarum (Green-top guideline no. 69). Royal College of Obstetricians & Gynaecologists. https://www.rcog.org.uk. 22 Jun 2016. Accessed 17 Aug 2016.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Children with high dental anxiety are more likely to develop dental diseases, which, in turn, negatively affect the family’s quality of life, a recent study has found.
2 days ago
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
14 Nov 2019
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
4 days ago
Supplementation with oral nano vitamin D appears to moderate disease activity and severity grade of patients with active ulcerative colitis (UC), suggests a study, adding that this association is more evident in those achieving a target vitamin D level of 40 ng/mL.